279
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Chick Chorioallantoic Membrane as an In Situ Biological Membrane for Pharmaceutical Formulation Development: A Review

, &
Pages 1168-1177 | Published online: 20 Oct 2008

REFERENCES

  • R. G. Alany, T. Rades, J. Nicoll, I. G. Tucker, and N. M. Davies. 2006. W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J. Control Release 111:145–152.
  • D. Anderson, and T. Russell. 1995. The status of alternative methods in toxicology. Cambridge, UK: The Royal Society of Chemistry.
  • D. H. Ausprunk, D. R. Knighton, and J. Folkman. 1974. Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic study. Dev. Biol 38:237–248.
  • W. I. B. Beveridge, and F. M. Burnet. 1946. The cultivation of viruses and rickettsiae in the chick embryo: His Majesty's Stationery Office. (Medical Research Council Special Rep. Series No. 256). London.
  • A. H. Brantner, F. Quehenberger, A. Chakraborty, J. Polligger, S. Sosa, and R. Della Loggia. 2002. HET-CAM bioassay as in vitro alternative to the croton oil test for investigating steroidal and non-steroidal compounds. Altex 19:51–56.
  • W. W. Chin, W. K. Lau, R. Bhuvaneswari, P. W. Heng, and M. Olivo. 2007. Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model. Cancer Lett. 245:127–133.
  • R. H. Clothier, K. A. Atkinson, M. J. Garle, R. K. Ward, and A. Willshaw. 1995. The development and evaluation of in vitro tests by the frame alternatives laboratory. Altern. Lab Anim. 23:75–90.
  • J. H. Draize. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol Exp. Ther. 82:377–390.
  • M. J. Hammer-Wilson, L. Akian, J. Espinoza, S. Kimel, and M. W. Berns. 1999. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers. J. Photochem. Photobiol. B 53:44–52.
  • M. J. Hammer-Wilson, D. Cao, S. Kimel, and M. W. Berns. 2002. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for photosensitizers administered intraperitoneally (IP) into the chick embryo. Photochem. Photobiol. Sci. 1:721–728.
  • J. J. Hidalgo. 2001. Assessing the absorption of new pharmaceuticals. Curr. Top. Med. Chem. 1:385–401.
  • R. Kolar. 2006. Animal experimentation. Sci. Eng. Ethics 12:111–122.
  • K. Kunzi-Rapp, F. Genze, R. Kufer, E. Reich, R. E. Hautmann, and J. E. Gschwend. 2001. Chorioallantoic membrane assay: vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model. J. Urol. 166:1502–1507.
  • K. Kunzi-Rapp, A. Ruck, and R. Kaufmann. 1999. Characterization of the chick chorioallantoic membrane model as a short-term in vivo system for human skin. Arch. Dermatol. Res. 291:290–295.
  • F. Lallemand, P. Furrer, O. Felt-Baeyens, M. Gex-Fabry, J. M. Dumont, K. Besseghir, and R. Gurny. 2005. A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics. Int. J. Pharm. 295:7–14.
  • N. Lange, J. P. Ballini, G. Wagnieres, and H. van den Bergh. 2001. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest. Ophthalmol. Vis. Sci. 42:38–46.
  • R. S. Lawrence, M. H. Groom, D. M. Ackroyd, and W. E. Parish. 1986. The chorioallantoic membrane in irritation testing. Food Chem. Toxicol. 24:497–502.
  • J. Leighton, J. Nassauer, R. Tchao, V. Gottfried, E. S. Lindenbaum, and S. Kimel. 1985. The chick embryo in toxicology: An alternative to the rabbit eye. Food Chem. Toxicol. 23:293–298.
  • N. P. Luepke. 1985. Hen's egg chorioallantoic membrane test for irritation potential. Food Chem. Toxicol. 23:287–291.
  • T. Leng, J. M. Miller, K. V. Bilbao, D. V. Palanker, P. Huie, and M. S. Blumenkranz. 2004. The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation. Retina 24:427–434.
  • M. E. Maragoudakis, M. Panoutsacopoulou, and M. Sarmonika. 1988. Rate of basement membrane biosynthesis as an index to angiogenesis. Tissue Cell 20:531–539.
  • T. Martins, J. Pauluhn, and L. Machemer. 1992. Analysis of alternative methods for determining ocular irritation. Food Chem Toxicol. 30:1061–1067.
  • J. F. McCormick, J. Nassauer, J. Bielunas, and J. Leighton. 1984. Anatomy of the chick chorioallantoic membrane relevant to its use as a substrate in bioassay systems. Scan Electron Microsc. 202:3–2030.
  • A. Mysliveckova, and Z. Rychter. 1975. Electron microscopy analysis of differentiation of the wall and capillary bed of the chick embryo allantochorion. Folia Morphol. (Praha) 23:306–319.
  • N. J. Neumann, E. Holzle, P. Lehmann, M. Rosenbruch, A. Klaucic, and G. Plewig. 1997. Photo hen's egg test: a model for phototoxicity. Br. J. Dermatol. 136:326–330.
  • P. K. Pawar, and D. K. Majumdar. 2006. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech., 7, Article 13, DOI: 10.1208/pt070113.
  • B. Pegaz, E. Debefve, J. P. Ballini, G. Wagnieres, S. Spaniol, V. Albrecht, D. V. Scheglmann, N. E. Nifantiev, H. van den Bergh, and Y. N. Konan-Kouakou. 2006. Photothrombic activity of m-THPC-loaded liposomal formulations: Pre-clinical assessment on chick chorioallantoic membrane model. Eur. J. Pharm. Sci. 28:134–140.
  • D. Ribatti, M. T. Conconi, B. Nico, S. Baiguera, P. Corsi, P. P. Parnigotto, and G. G. Nussdorfer. 2003. Angiogenic response induced by acellular brain scaffolds grafted onto the chick embryo chorioallantoic membrane. Brain Res. 989:9–15.
  • D. Ribatti, B. Nico, L. Morbidelli, S. Donnini, M. Ziche, A. Vacca, L. Roncali, and M. Presta. 2001. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. J. Vasc. Res. 38:389–397.
  • D. Ribatti, B. Nico, A. Vacca, L. Roncali, P. H. Burri, and V. Djonov. 2001. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat. Rec. 264:317–324.
  • D. Ribatti, B. Nico, A. Vacca, L. Roncali, and M. Presta. 1999. Endogenous and exogenous fibroblast growth factor-2 modulate wound healing in the chick embryo chorioallantoic membrane. Angiogenesis 3:89–95.
  • M. Richardson, and G. Singh. 2003. Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. Curr. Drug Targets Cardiovasc. Haematol. Disord. 3:155–185.
  • A. L. Romanoff, and A. J. Romanoff. 1967. Biochemistry of the avian embryo: A quantitative analysis of prenatal development. New York: Interscience Publisher.
  • P. Rous, and J. B. Murphy. 1911. Tumor implantations in the developing embryo. JAMA 56:741–742.
  • A. Ruck, K. Akgun, K. Heckelsmiller, G. Beck, F. Genze, and R. Steiner. 1998. Confocal observation of hydrophilic and lipophilic photosensitizers in endothelial cells, lumen of the vessels, interstitium and tumor cells using the chicken chorioallantoic membrane. SPIE 3247:63–68.
  • W. M. S. Russell, and R. L. Burch. 1959. The principles of humane experimental technique. Springfield, IL: Charles C. Thomas, Co.
  • C. L. Saw, P. W. Heng, W. W. Chin, K. C. Soo, and M. Olivo. 2006. Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model. Cancer Lett. 238:104–110.
  • C. L. Saw, M. Olivo, W. W. Chin, K. C. Soo, and P. W. Heng. 2005. Transport of hypericin across chick chorioallantoic membrane and photodynamic therapy vasculature assessment. Biol. Pharm. Bull. 28:1054–1060.
  • C. L. Saw, M. Olivo, W. W. Chin, K. C. Soo, and P. W. Heng. 2007. Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model. J. Photochem. Photobiol. B 86:207–218.
  • A. Vargas, M. Eid, M. Fanchaouy, R. Gurny, and F. Delie. 2008. In vivo photodynamic activity of photosensitizer-loaded nanoparticles: Formulation properties, administration parameters and biological issues involved in PDT outcome. Eur. J. Pharm. Biopharm. 69:43–53.
  • A. Vargas, B. Pegaz, E. Debefve, Y. Konan-Kouakou, N. Lange, J. P. Ballini, H. van den Bergh, R. Gurny, and F. Delie. 2004. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int. J. Pharm. 286:131–145.
  • C. Wigglesworth. 2006. Grants proposals and animal use protocols: is the IACUC playing by the rules? A word from OLAW. Lab Anim. (NY) 35:18.
  • C. I. Winternitz, J. K. Jackson, A. M. Oktaba, and H. M. Burt. 1996. Development of a polymeric surgical paste formulation for taxol. Pharm. Res. 13:368–375.
  • P. Wutzler, A. Sauerbrei, A. Härtl, and K. Reimer. 2003. Comparative testing of liposomal and aqueous formulations of povidone-iodine for their angioirritative potential at the chorioallantoic membrane of ex ovo cultivated chick embryos. Dermatology 207:43–47.
  • E. Zwilling. 1959. A modified chorioallantoic grafting procedure. Transplant. Bull. 6:115–116.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.